radium Ra 223 dichloride + Laboratory Biomarker Analysis + Enzalutamide

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

radium Ra 223 dichloride + Laboratory Biomarker Analysis + Enzalutamide
Treatment and conditionWhere it standsTrials
radium Ra 223 dichloride + Laboratory Biomarker Analysis + Enzalutamide for prostatic neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1